1. Home
  2. ATYR vs CZNC Comparison

ATYR vs CZNC Comparison

Compare ATYR & CZNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATYR
  • CZNC
  • Stock Information
  • Founded
  • ATYR 2005
  • CZNC 1864
  • Country
  • ATYR United States
  • CZNC United States
  • Employees
  • ATYR N/A
  • CZNC N/A
  • Industry
  • ATYR Biotechnology: Biological Products (No Diagnostic Substances)
  • CZNC Major Banks
  • Sector
  • ATYR Health Care
  • CZNC Finance
  • Exchange
  • ATYR Nasdaq
  • CZNC Nasdaq
  • Market Cap
  • ATYR 327.0M
  • CZNC 330.3M
  • IPO Year
  • ATYR 2015
  • CZNC N/A
  • Fundamental
  • Price
  • ATYR $2.96
  • CZNC $20.04
  • Analyst Decision
  • ATYR Strong Buy
  • CZNC
  • Analyst Count
  • ATYR 6
  • CZNC 0
  • Target Price
  • ATYR $18.60
  • CZNC N/A
  • AVG Volume (30 Days)
  • ATYR 1.5M
  • CZNC 22.9K
  • Earning Date
  • ATYR 03-13-2025
  • CZNC 05-06-2025
  • Dividend Yield
  • ATYR N/A
  • CZNC 5.61%
  • EPS Growth
  • ATYR N/A
  • CZNC 7.45
  • EPS
  • ATYR N/A
  • CZNC 1.69
  • Revenue
  • ATYR $235,000.00
  • CZNC $106,129,000.00
  • Revenue This Year
  • ATYR $1,387.23
  • CZNC $9.38
  • Revenue Next Year
  • ATYR $873.22
  • CZNC $3.77
  • P/E Ratio
  • ATYR N/A
  • CZNC $11.83
  • Revenue Growth
  • ATYR N/A
  • CZNC 1.43
  • 52 Week Low
  • ATYR $1.42
  • CZNC $16.50
  • 52 Week High
  • ATYR $4.66
  • CZNC $22.68
  • Technical
  • Relative Strength Index (RSI)
  • ATYR 37.05
  • CZNC 43.88
  • Support Level
  • ATYR $3.20
  • CZNC $19.59
  • Resistance Level
  • ATYR $3.94
  • CZNC $20.71
  • Average True Range (ATR)
  • ATYR 0.25
  • CZNC 0.41
  • MACD
  • ATYR -0.08
  • CZNC -0.03
  • Stochastic Oscillator
  • ATYR 9.33
  • CZNC 32.37

About ATYR aTyr Pharma Inc. Common Stock

aTyr Pharma Inc is a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform. The company has concentrated its research and development efforts on a newly discovered area of biology, the extracellular functionality and signaling pathways of tRNA synthetases. Its primary focus is efzofitimod, a clinical-stage product candidate which targets NRP2 to resolve chronic inflammation that can cause to fibrosis. Efzofitimod has a novel mechanism of action for potentially treating lung inflammation and fibrosis.

About CZNC Citizens & Northern Corp

Citizens & Northern Corp is a community bank operating through its subsidiaries. It provides banking services, including deposit and loan products for personal and commercial customers. The bank also maintains a trust division that provides a wide range of financial services, such as 401(k) plans, retirement planning, estate planning, estate settlements and asset management.

Share on Social Networks: